Cipla EU to invest € 15 million in Ethris
Cipla and Ethris partner for the development of mRNA-based therapies
Cipla and Ethris partner for the development of mRNA-based therapies
All claims against the company in the litigation have now been dismissed.
This ambitious anti-TB campaign, as part of IOCL’s CSR, aims to ensure early identification of presumptive TB and prompt diagnosis using high-sensitivity diagnostic tests at the doorstep
For anaemia control in children (0-19 years) & resolves for Call to Action in this direction
Yonghe as the CDMO partner will provide production process development and cGMP manufacturing services for Ablaze
Advent will also be making an open offer to acquire additional 26% of the outstanding equity shares of the company from the public shareholders.
Modi stressed the need to ensure that the entire Covid infrastructure at all levels is maintained at a high level of preparedness in terms of equipment, processes, and human resources
The expansion in Indore is well-aligned with Lupin Diagnostics’ commitment to improving access to high-quality, reliable, and advanced testing centres and home collection facilities at an affordable price
He has published more than 100 research papers in several prestigious national and international journals
Subscribe To Our Newsletter & Stay Updated